| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix constituent conferring elasticity | 3.01e-06 | 12 | 49 | 3 | GO:0030023 | |
| GeneOntologyMolecularFunction | structural molecule activity conferring elasticity | 4.96e-06 | 14 | 49 | 3 | GO:0097493 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 7.60e-06 | 16 | 49 | 3 | GO:0005041 | |
| GeneOntologyMolecularFunction | calcium ion binding | 1.13e-05 | 749 | 49 | 10 | GO:0005509 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 1.79e-05 | 21 | 49 | 3 | GO:0030228 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 9.56e-05 | 188 | 49 | 5 | GO:0005201 | |
| GeneOntologyMolecularFunction | GTPase activator activity | 5.93e-04 | 279 | 49 | 5 | GO:0005096 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 1.19e-03 | 85 | 49 | 3 | GO:0038024 | |
| GeneOntologyMolecularFunction | methylation-dependent protein binding | 1.32e-03 | 88 | 49 | 3 | GO:0140034 | |
| GeneOntologyMolecularFunction | scavenger receptor activity | 1.99e-03 | 27 | 49 | 2 | GO:0005044 | |
| GeneOntologyMolecularFunction | molecular function activator activity | FBN1 FBN2 BICRA RASGRP3 ARHGAP26 WNT9A SIPA1L2 ARHGAP21 TBC1D20 | 2.77e-03 | 1233 | 49 | 9 | GO:0140677 |
| GeneOntologyMolecularFunction | ubiquitin conjugating enzyme binding | 3.52e-03 | 36 | 49 | 2 | GO:0031624 | |
| GeneOntologyMolecularFunction | protein-disulfide reductase activity | 3.52e-03 | 36 | 49 | 2 | GO:0015035 | |
| GeneOntologyBiologicalProcess | sequestering of TGFbeta in extracellular matrix | 3.17e-05 | 4 | 48 | 2 | GO:0035583 | |
| GeneOntologyBiologicalProcess | negative regulation of proteolysis | 1.04e-04 | 326 | 48 | 6 | GO:0045861 | |
| GeneOntologyBiologicalProcess | negative regulation of signal transduction by p53 class mediator | 1.18e-04 | 41 | 48 | 3 | GO:1901797 | |
| GeneOntologyBiologicalProcess | maintenance of protein location in extracellular region | 1.47e-04 | 8 | 48 | 2 | GO:0071694 | |
| GeneOntologyBiologicalProcess | regulation of signal transduction by p53 class mediator | 1.68e-04 | 119 | 48 | 4 | GO:1901796 | |
| GeneOntologyCellularComponent | microfibril | 3.40e-06 | 13 | 49 | 3 | GO:0001527 | |
| GeneOntologyCellularComponent | GBAF complex | 4.81e-04 | 14 | 49 | 2 | GO:0140288 | |
| HumanPheno | Abnormal upper to lower segment ratio | 3.14e-05 | 3 | 17 | 2 | HP:0012772 | |
| HumanPheno | Dolichocephaly | 4.90e-05 | 219 | 17 | 6 | HP:0000268 | |
| Domain | cEGF | 5.25e-11 | 26 | 49 | 6 | IPR026823 | |
| Domain | cEGF | 5.25e-11 | 26 | 49 | 6 | PF12662 | |
| Domain | EGF_CA | 9.47e-10 | 122 | 49 | 8 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 1.08e-09 | 124 | 49 | 8 | IPR001881 | |
| Domain | EGF_CA | 2.51e-09 | 86 | 49 | 7 | PF07645 | |
| Domain | EGF_Ca-bd_CS | 5.88e-09 | 97 | 49 | 7 | IPR018097 | |
| Domain | Growth_fac_rcpt_ | 6.67e-09 | 156 | 49 | 8 | IPR009030 | |
| Domain | EGF_CA | 6.79e-09 | 99 | 49 | 7 | PS01187 | |
| Domain | ASX_HYDROXYL | 7.29e-09 | 100 | 49 | 7 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 1.10e-08 | 106 | 49 | 7 | IPR000152 | |
| Domain | FBN | 1.70e-08 | 3 | 49 | 3 | IPR011398 | |
| Domain | EGF_3 | 1.61e-07 | 235 | 49 | 8 | PS50026 | |
| Domain | EGF | 1.61e-07 | 235 | 49 | 8 | SM00181 | |
| Domain | EGF-like_dom | 2.51e-07 | 249 | 49 | 8 | IPR000742 | |
| Domain | EGF_1 | 3.01e-07 | 255 | 49 | 8 | PS00022 | |
| Domain | EGF-like_CS | 3.59e-07 | 261 | 49 | 8 | IPR013032 | |
| Domain | EGF_2 | 4.03e-07 | 265 | 49 | 8 | PS01186 | |
| Domain | TB | 5.90e-07 | 7 | 49 | 3 | PF00683 | |
| Domain | - | 9.42e-07 | 8 | 49 | 3 | 3.90.290.10 | |
| Domain | TB | 1.41e-06 | 9 | 49 | 3 | PS51364 | |
| Domain | TB_dom | 1.41e-06 | 9 | 49 | 3 | IPR017878 | |
| Domain | DUF5050 | 6.74e-06 | 2 | 49 | 2 | IPR032485 | |
| Domain | DUF5050 | 6.74e-06 | 2 | 49 | 2 | PF16472 | |
| Domain | GSCR1_dom | 6.74e-06 | 2 | 49 | 2 | IPR015671 | |
| Domain | GLTSCR1 | 6.74e-06 | 2 | 49 | 2 | PF15249 | |
| Domain | EGF | 1.94e-05 | 126 | 49 | 5 | PF00008 | |
| Domain | hEGF | 5.31e-05 | 28 | 49 | 3 | PF12661 | |
| Domain | - | 1.59e-04 | 449 | 49 | 7 | 3.30.40.10 | |
| Domain | Znf_RING/FYVE/PHD | 1.82e-04 | 459 | 49 | 7 | IPR013083 | |
| Domain | Znf_FYVE_PHD | 5.93e-04 | 147 | 49 | 4 | IPR011011 | |
| Domain | Ldl_recept_b | 6.01e-04 | 14 | 49 | 2 | PF00058 | |
| Domain | LDLRB | 6.01e-04 | 14 | 49 | 2 | PS51120 | |
| Domain | Zinc_finger_PHD-type_CS | 6.61e-04 | 65 | 49 | 3 | IPR019786 | |
| Domain | LY | 6.93e-04 | 15 | 49 | 2 | SM00135 | |
| Domain | LDLR_classB_rpt | 6.93e-04 | 15 | 49 | 2 | IPR000033 | |
| Domain | Znf_RING | 1.60e-03 | 326 | 49 | 5 | IPR001841 | |
| Domain | ZF_PHD_1 | 2.04e-03 | 96 | 49 | 3 | PS01359 | |
| Domain | - | 4.70e-03 | 39 | 49 | 2 | 2.120.10.30 | |
| Domain | LDLR_class-A_CS | 4.94e-03 | 40 | 49 | 2 | IPR023415 | |
| Domain | Ldl_recept_a | 6.21e-03 | 45 | 49 | 2 | PF00057 | |
| Domain | - | 6.48e-03 | 46 | 49 | 2 | 4.10.400.10 | |
| Domain | 6-blade_b-propeller_TolB-like | 6.48e-03 | 46 | 49 | 2 | IPR011042 | |
| Domain | LDLRA_1 | 7.04e-03 | 48 | 49 | 2 | PS01209 | |
| Domain | LDLRA_2 | 7.33e-03 | 49 | 49 | 2 | PS50068 | |
| Domain | LDrepeatLR_classA_rpt | 7.33e-03 | 49 | 49 | 2 | IPR002172 | |
| Domain | LDLa | 7.33e-03 | 49 | 49 | 2 | SM00192 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 2.23e-06 | 37 | 36 | 4 | M27134 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 4.52e-06 | 44 | 36 | 4 | M26969 | |
| Pathway | WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE | 3.38e-05 | 25 | 36 | 3 | M39713 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 7.21e-05 | 32 | 36 | 3 | MM14854 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 1.31e-04 | 39 | 36 | 3 | MM14601 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 4.29e-04 | 140 | 36 | 4 | M587 | |
| Pathway | REACTOME_RHOJ_GTPASE_CYCLE | 7.44e-04 | 16 | 36 | 2 | MM15605 | |
| Pubmed | Heparin/heparan sulfate controls fibrillin-1, -2 and -3 self-interactions in microfibril assembly. | 1.19e-08 | 4 | 51 | 3 | 25034023 | |
| Pubmed | Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins. | 3.95e-07 | 101 | 51 | 5 | 23382219 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 12399449 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 21851253 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 12429739 | ||
| Pubmed | Striking differences of LDL receptor-related protein 1B expression in mouse and human. | 2.11e-06 | 2 | 51 | 2 | 15963947 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 9886271 | ||
| Pubmed | New Evidence Supporting the Role of FBN1 in the Development of Adolescent Idiopathic Scoliosis. | 2.11e-06 | 2 | 51 | 2 | 30044367 | |
| Pubmed | Material and mechanical properties of bones deficient for fibrillin-1 or fibrillin-2 microfibrils. | 2.11e-06 | 2 | 51 | 2 | 21440062 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 15131124 | ||
| Pubmed | Fibrillin-1 and fibrillin-2 in human embryonic and early fetal development. | 2.11e-06 | 2 | 51 | 2 | 12524050 | |
| Pubmed | Microfibril structure masks fibrillin-2 in postnatal tissues. | 2.11e-06 | 2 | 51 | 2 | 20404337 | |
| Pubmed | Fibrillln mutations in Marfan syndrome and related phenotypes. | 2.11e-06 | 2 | 51 | 2 | 8791520 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 8120105 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 35419902 | ||
| Pubmed | Fibrillin genes map to regions of conserved mouse/human synteny on mouse chromosomes 2 and 18. | 2.11e-06 | 2 | 51 | 2 | 8307578 | |
| Pubmed | Fibrillin assembly: dimer formation mediated by amino-terminal sequences. | 2.11e-06 | 2 | 51 | 2 | 10504303 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 15221638 | ||
| Pubmed | Developmental expression of fibrillin genes suggests heterogeneity of extracellular microfibrils. | 2.11e-06 | 2 | 51 | 2 | 7744963 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 26408953 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 32743796 | ||
| Pubmed | Arg-Gly-Asp-containing domains of fibrillins-1 and -2 distinctly regulate lung fibroblast migration. | 2.11e-06 | 2 | 51 | 2 | 18006876 | |
| Pubmed | Rare variants in FBN1 and FBN2 are associated with severe adolescent idiopathic scoliosis. | 2.11e-06 | 2 | 51 | 2 | 24833718 | |
| Pubmed | Fibrillin-1 and fibulin-2 interact and are colocalized in some tissues. | 2.11e-06 | 2 | 51 | 2 | 8702639 | |
| Pubmed | Exome sequencing identified new mutations in a Marfan syndrome family. | 2.11e-06 | 2 | 51 | 2 | 24484584 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 24265020 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 20529844 | ||
| Pubmed | Immunohistochemical expression of fibrillin-1 and fibrillin-2 during tooth development. | 2.11e-06 | 2 | 51 | 2 | 25524144 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 23133647 | ||
| Pubmed | Fibrillins 1 and 2 perform partially overlapping functions during aortic development. | 2.11e-06 | 2 | 51 | 2 | 16407178 | |
| Pubmed | Linkage of Marfan syndrome and a phenotypically related disorder to two different fibrillin genes. | 2.11e-06 | 2 | 51 | 2 | 1852206 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 10359653 | ||
| Pubmed | 3.71e-06 | 71 | 51 | 4 | 33541421 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 10825173 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 30201140 | ||
| Pubmed | TNF is a key mediator of septic encephalopathy acting through its receptor, TNF receptor-1. | 6.32e-06 | 3 | 51 | 2 | 17884256 | |
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 20855508 | ||
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 12429738 | ||
| Pubmed | Human eye development is characterized by coordinated expression of fibrillin isoforms. | 1.26e-05 | 4 | 51 | 2 | 25406291 | |
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 20729550 | ||
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 16835936 | ||
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 38462037 | ||
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 15610515 | ||
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 17065459 | ||
| Pubmed | 2.10e-05 | 5 | 51 | 2 | 26601954 | ||
| Pubmed | 2.10e-05 | 5 | 51 | 2 | 20516000 | ||
| Pubmed | 2.10e-05 | 5 | 51 | 2 | 12590922 | ||
| Pubmed | 2.10e-05 | 5 | 51 | 2 | 17255108 | ||
| Pubmed | 2.10e-05 | 5 | 51 | 2 | 34411563 | ||
| Pubmed | Development, composition, and structural arrangements of the ciliary zonule of the mouse. | 2.10e-05 | 5 | 51 | 2 | 23493297 | |
| Pubmed | 3.15e-05 | 6 | 51 | 2 | 19349279 | ||
| Pubmed | 3.15e-05 | 6 | 51 | 2 | 7873879 | ||
| Pubmed | Regulation of limb patterning by extracellular microfibrils. | 4.41e-05 | 7 | 51 | 2 | 11470817 | |
| Pubmed | 5.55e-05 | 50 | 51 | 3 | 23658023 | ||
| Pubmed | Putative functions of extracellular matrix glycoproteins in secondary palate morphogenesis. | 5.87e-05 | 8 | 51 | 2 | 23055981 | |
| Pubmed | Adamts17 is involved in skeletogenesis through modulation of BMP-Smad1/5/8 pathway. | 5.87e-05 | 8 | 51 | 2 | 31201465 | |
| Pubmed | EMILIN proteins are novel extracellular constituents of the dentin-pulp complex. | 5.87e-05 | 8 | 51 | 2 | 32948785 | |
| Pubmed | Targeting of bone morphogenetic protein growth factor complexes to fibrillin. | 5.87e-05 | 8 | 51 | 2 | 18339631 | |
| Pubmed | 7.54e-05 | 9 | 51 | 2 | 35170427 | ||
| Pubmed | 7.54e-05 | 9 | 51 | 2 | 12122015 | ||
| Pubmed | 7.54e-05 | 9 | 51 | 2 | 38844137 | ||
| Pubmed | 9.42e-05 | 10 | 51 | 2 | 30738849 | ||
| Pubmed | 1.15e-04 | 11 | 51 | 2 | 24639464 | ||
| Pubmed | 1.15e-04 | 11 | 51 | 2 | 12881723 | ||
| Pubmed | 1.29e-04 | 175 | 51 | 4 | 28071719 | ||
| Pubmed | 1.38e-04 | 12 | 51 | 2 | 36779913 | ||
| Pubmed | 1.38e-04 | 12 | 51 | 2 | 26405179 | ||
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | 1.45e-04 | 1061 | 51 | 8 | 33845483 | |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 1.56e-04 | 184 | 51 | 4 | 32908313 | |
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | 1.65e-04 | 560 | 51 | 6 | 21653829 | |
| Pubmed | 1.90e-04 | 14 | 51 | 2 | 30510198 | ||
| Pubmed | 1.90e-04 | 14 | 51 | 2 | 15082773 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | 1.92e-04 | 1105 | 51 | 8 | 35748872 | |
| Pubmed | 2.05e-04 | 1116 | 51 | 8 | 31753913 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | 2.36e-04 | 853 | 51 | 7 | 28718761 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 2.49e-04 | 861 | 51 | 7 | 36931259 | |
| Pubmed | Role of TNF ligand and receptor family in the lymphoid organogenesis defined by gene targeting. | 2.50e-04 | 16 | 51 | 2 | 10687308 | |
| Pubmed | 2.51e-04 | 83 | 51 | 3 | 9039502 | ||
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 2.79e-04 | 86 | 51 | 3 | 28327460 | |
| Pubmed | Proteolysis of fibrillin-2 microfibrils is essential for normal skeletal development. | 3.18e-04 | 18 | 51 | 2 | 35503090 | |
| Pubmed | 3.18e-04 | 18 | 51 | 2 | 19838193 | ||
| Pubmed | ADAMTS18-fibronectin interaction regulates the morphology of liver sinusoidal endothelial cells. | 3.18e-04 | 18 | 51 | 2 | 39040056 | |
| Pubmed | USP53 plays an antitumor role in hepatocellular carcinoma through deubiquitination of cytochrome c. | 3.19e-04 | 90 | 51 | 3 | 35654790 | |
| Pubmed | 3.23e-04 | 407 | 51 | 5 | 12693553 | ||
| Pubmed | Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. | 3.29e-04 | 91 | 51 | 3 | 21833088 | |
| Pubmed | 3.36e-04 | 225 | 51 | 4 | 12168954 | ||
| Pubmed | 3.65e-04 | 418 | 51 | 5 | 34709266 | ||
| Pubmed | MESD is essential for apical localization of megalin/LRP2 in the visceral endoderm. | 4.35e-04 | 21 | 51 | 2 | 21337463 | |
| Pubmed | 5.01e-04 | 105 | 51 | 3 | 22493164 | ||
| Pubmed | 5.15e-04 | 106 | 51 | 3 | 18654987 | ||
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | 5.23e-04 | 695 | 51 | 6 | 23602568 | |
| Pubmed | High-density polymorphisms analysis of 23 candidate genes for association with bone mineral density. | 5.23e-04 | 23 | 51 | 2 | 20654748 | |
| Pubmed | 6.19e-04 | 25 | 51 | 2 | 23042114 | ||
| Pubmed | Adamts18 modulates the development of the aortic arch and common carotid artery. | 6.70e-04 | 26 | 51 | 2 | 34189436 | |
| Pubmed | 7.23e-04 | 27 | 51 | 2 | 29374058 | ||
| Pubmed | Structure and evolution of the Smith-Magenis syndrome repeat gene clusters, SMS-REPs. | 8.35e-04 | 29 | 51 | 2 | 11997339 | |
| Pubmed | ADAMTS18 Deficiency Leads to Pulmonary Hypoplasia and Bronchial Microfibril Accumulation. | 8.93e-04 | 30 | 51 | 2 | 32882513 | |
| Pubmed | 8.93e-04 | 30 | 51 | 2 | 20301299 | ||
| Pubmed | TBX1 is required for normal stria vascularis and semicircular canal development. | 9.54e-04 | 31 | 51 | 2 | 31550482 | |
| Pubmed | 9.54e-04 | 31 | 51 | 2 | 25762570 | ||
| Interaction | ZNF408 interactions | 6.65e-08 | 145 | 50 | 7 | int:ZNF408 | |
| Interaction | ZFP41 interactions | 2.91e-07 | 57 | 50 | 5 | int:ZFP41 | |
| Interaction | NTN5 interactions | 3.43e-07 | 24 | 50 | 4 | int:NTN5 | |
| Interaction | FOXD4L6 interactions | 6.54e-06 | 49 | 50 | 4 | int:FOXD4L6 | |
| Interaction | HRG interactions | 1.79e-05 | 63 | 50 | 4 | int:HRG | |
| Interaction | SLMAP interactions | 3.35e-05 | 149 | 50 | 5 | int:SLMAP | |
| Interaction | ELN interactions | 5.02e-05 | 29 | 50 | 3 | int:ELN | |
| Interaction | LTBP1 interactions | 7.98e-05 | 92 | 50 | 4 | int:LTBP1 | |
| Interaction | ZNF594 interactions | 1.26e-04 | 7 | 50 | 2 | int:ZNF594 | |
| GeneFamily | Low density lipoprotein receptors | 2.80e-04 | 13 | 35 | 2 | 634 | |
| GeneFamily | PHD finger proteins | 6.96e-04 | 90 | 35 | 3 | 88 | |
| GeneFamily | Ring finger proteins | 1.89e-03 | 275 | 35 | 4 | 58 | |
| GeneFamily | Rho GTPase activating proteins|BCH domain containing | 4.21e-03 | 50 | 35 | 2 | 721 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 5.10e-03 | 181 | 35 | 3 | 694 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 2.20e-06 | 200 | 50 | 6 | M5930 | |
| Coexpression | GSE4984_UNTREATED_VS_VEHICLE_CTRL_TREATED_DC_UP | 1.16e-05 | 155 | 50 | 5 | M6500 | |
| Coexpression | GSE19941_UNSTIM_VS_LPS_STIM_IL10_KO_MACROPHAGE_UP | 3.85e-05 | 199 | 50 | 5 | M8105 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.90e-06 | 195 | 51 | 5 | f54bc4454270ff06e85596f98199372b50d0179f | |
| ToppCell | Caecum-(6)_Macrophage-(61)_LYVE1_Macrophage|Caecum / shred on region, Cell_type, and subtype | 3.13e-06 | 198 | 51 | 5 | e684c3934c163aef4d284b69435832d2c9614f2a | |
| ToppCell | Caecum-Macrophage-LYVE1_Macrophage|Caecum / Region, Cell class and subclass | 3.13e-06 | 198 | 51 | 5 | a92c0cacb775aca6bbb302bd9e22c081a112a44d | |
| ToppCell | Control_saline-Endothelial-Endothelial-Vein|Control_saline / Treatment groups by lineage, cell group, cell type | 3.28e-06 | 200 | 51 | 5 | e5f876910bc8cb390d9b46a48d9b6d4d57235551 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c4-CD14-CD16|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.49e-05 | 148 | 51 | 4 | fd0d8386b94adb1bdc993fbb44d2d87852bfd7f0 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.06e-05 | 156 | 51 | 4 | 895927228c93cd090303984c5be6ebfb59ed6f3a | |
| ToppCell | E12.5-Endothelial-lymphatic_endothelial_cell-endothelial_cell_of_lymphatic_vessel|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.63e-05 | 163 | 51 | 4 | c21114826bee1b05b411984326fef6b6e0d05316 | |
| ToppCell | E12.5-Endothelial-lymphatic_endothelial_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.63e-05 | 163 | 51 | 4 | 5d49414432db259a19df50d7944581d00b69f537 | |
| ToppCell | facs|World / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.38e-05 | 171 | 51 | 4 | c9990bc041a632b2f7bbebbfe737772c423d7027 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.48e-05 | 172 | 51 | 4 | e37c0b5b547a7345179ab258dd2141fec7064c17 | |
| ToppCell | facs|World / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.48e-05 | 172 | 51 | 4 | a2d0a64ebf09d219a07d6bbad1056bad6d46b9be | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_12|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.58e-05 | 173 | 51 | 4 | a55f310c533432e9e26e400026a5b47245152976 | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_12|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.58e-05 | 173 | 51 | 4 | 9c7386bf0a899882c733f0b4921a96afde032a7d | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.90e-05 | 176 | 51 | 4 | 2e94bbe17c0bb65dc58b4ebc0cb829258bd7373b | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.90e-05 | 176 | 51 | 4 | f33ab41d121b59d871ad7d48ca021524a027d2ef | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.01e-05 | 177 | 51 | 4 | 227d4f423b00be2e0c5797e2c5275d342e69a0f4 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.01e-05 | 177 | 51 | 4 | 66ffa279147961080c104242a08b176e301d80e3 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.01e-05 | 177 | 51 | 4 | 0cbf54608d2ba0a0500af142f2029fe5e118c3c2 | |
| ToppCell | facs-Kidney-nan-24m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.35e-05 | 180 | 51 | 4 | f9f8245cbcdea18c15e2976c85b72c6807309787 | |
| ToppCell | facs-Kidney-nan-24m-Mesenchymal-kidney_interstitial_fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.46e-05 | 181 | 51 | 4 | c7f5aedcb74c21fb587a95a16d700e2a38a380ee | |
| ToppCell | facs-Kidney-nan-24m-Mesenchymal-kidney_interstitial_fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.46e-05 | 181 | 51 | 4 | 0ec9621a078d004bbd25a587757d24b5cf162959 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.58e-05 | 182 | 51 | 4 | d179b5deb07c20d49eb6c58d5a65904f8921de3a | |
| ToppCell | Control-Endothelial-Endothelial-Alv_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.20e-05 | 187 | 51 | 4 | ea9d34bcd3bd1f36745846309ede349773de501a | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.20e-05 | 187 | 51 | 4 | ed7ab4cf4629d96dad5c74d536fc428d0a8d4eb9 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.33e-05 | 188 | 51 | 4 | c32d023a69b6da79687ff8fa7485e7499db57046 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.33e-05 | 188 | 51 | 4 | ce85a56ac27a6432421dde93a1bafa8b943244b9 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.33e-05 | 188 | 51 | 4 | 1cd5a4d744bd3777246958ea5eb94388a5cbad81 | |
| ToppCell | facs-GAT-Fat-24m-Mesenchymal|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.59e-05 | 190 | 51 | 4 | 3720e64129f3f3268b1dc14031a76f41c38241c2 | |
| ToppCell | facs-GAT-Fat-24m-Mesenchymal-mesenchymal_progenitor|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.59e-05 | 190 | 51 | 4 | 73a50426f972f08f9bb525ad5c0b774187ab5d6a | |
| ToppCell | facs-GAT-Fat-24m-Mesenchymal-mesenchymal_stem_cell_of_adipose|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.59e-05 | 190 | 51 | 4 | b55cf1fb586b724295b7b038483249847bb344fc | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.87e-05 | 192 | 51 | 4 | 853a930e0641ffb50cbb4cef5837c70d75c3fc39 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.87e-05 | 192 | 51 | 4 | a2c31390da4962bda9a936470b0b68fa1f5d47d1 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.87e-05 | 192 | 51 | 4 | eeab1cef7c36ae824381952c5b2c982368c379fd | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.87e-05 | 192 | 51 | 4 | d2c03490c5e835d0f0a732803093c64b8d4b4029 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.87e-05 | 192 | 51 | 4 | 49281626ecad0456fdbded2378b7028d7b589686 | |
| ToppCell | Children_(3_yrs)-Immune-monocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.01e-05 | 193 | 51 | 4 | 58e1930a1d80ad3729ab9604ac8ebf7308232a3d | |
| ToppCell | LA|World / Chamber and Cluster_Paper | 7.01e-05 | 193 | 51 | 4 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | facs-Kidney-nan-18m-Mesenchymal-mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.15e-05 | 194 | 51 | 4 | bbc625b4cc53bb7d6254fde287258e51f9171572 | |
| ToppCell | IPF-Stromal-Fibroblast|Stromal / Disease state, Lineage and Cell class | 7.15e-05 | 194 | 51 | 4 | da3e1d39575969a069ef43e552afe94b2f441d0b | |
| ToppCell | facs-Kidney-nan-18m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.15e-05 | 194 | 51 | 4 | fcd5e9238d299c41f0bf9693b56cd8c900d2112b | |
| ToppCell | Control-Classical_Monocyte|Control / Disease condition and Cell class | 7.15e-05 | 194 | 51 | 4 | 9e33e1b54b4114f9e6981819834bb796ed7192b5 | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 7.15e-05 | 194 | 51 | 4 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | facs-Kidney-nan-18m-Mesenchymal-mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.15e-05 | 194 | 51 | 4 | 6afc21c5fec30ab8e373e3e46ab7866204c805b6 | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 7.29e-05 | 195 | 51 | 4 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | facs-Heart-LA-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.29e-05 | 195 | 51 | 4 | 79a6e8e6de040ff07539e8901fc407363a50e355 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.29e-05 | 195 | 51 | 4 | 752a100297c26732e12bbbf3ab27a2bd4f5ea06d | |
| ToppCell | facs-Heart-LA-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.44e-05 | 196 | 51 | 4 | ad1838dabd043cb140260843e3527d8c7d58850e | |
| ToppCell | facs-Heart-LA-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.44e-05 | 196 | 51 | 4 | cbc15c0769016fe9972445169029bd8d14a7e6ef | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.58e-05 | 197 | 51 | 4 | 8af4a1e35ce9fb4ea3d26ab619599efb7eac43a5 | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-E|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 7.58e-05 | 197 | 51 | 4 | 9b1c1d72c5a8c90d71ae31e4c198d2276872eaa0 | |
| ToppCell | facs-Heart-LA-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.58e-05 | 197 | 51 | 4 | 2a91738cb6d7588869dd00deeea0cbbc2d6aa34d | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.58e-05 | 197 | 51 | 4 | c747c496ac090309b7f8a3e9d840928f12c83f2f | |
| ToppCell | severe-HLA-DR+_CD83+_Monocyte|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.73e-05 | 198 | 51 | 4 | a77f3440d7fb6a50066abc7e9ad59e83798ef13d | |
| ToppCell | 368C-Fibroblasts-Fibroblast-D-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 7.89e-05 | 199 | 51 | 4 | 8766796041965a1ba40ad7abdbc244bf1418c209 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.89e-05 | 199 | 51 | 4 | 333056c2abe9724efeab542c0365fcfe4eff8f18 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.89e-05 | 199 | 51 | 4 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.89e-05 | 199 | 51 | 4 | e60ecbb8fa7bcd3e2ce7d78f6efb2cfd1fd77698 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.89e-05 | 199 | 51 | 4 | fb580e9321ddf97c73b2e356cd82523db74a38a2 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-D|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 7.89e-05 | 199 | 51 | 4 | d39b40d84c72bdde756b805063317ecfad3784f8 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.04e-05 | 200 | 51 | 4 | cfea2f9d85646c9b722150551ff2e8fc4f6cc98a | |
| ToppCell | 390C-Fibroblasts-Fibroblast-H|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 8.04e-05 | 200 | 51 | 4 | 019340e8b4b4944a49e14fdec7ce2954cbb8ba2e | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.04e-05 | 200 | 51 | 4 | 6f7f015b5fa1f52374f2c7d9ba339012395eda5f | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.04e-05 | 200 | 51 | 4 | 8ab0051544ea32eb8b3f7f8ba7582deaf8bf26c0 | |
| ToppCell | control-HLA-DR-_S100A+_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.04e-05 | 200 | 51 | 4 | 107a0665fb20247511a430178effd7630a619488 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Vein|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 8.04e-05 | 200 | 51 | 4 | b3f93b71589251197cde96b7bc6d065c106f61cd | |
| ToppCell | 390C-Fibroblasts-Fibroblast-H-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 8.04e-05 | 200 | 51 | 4 | b6f21f5cc137eddf6ba90e81cae791b57d88d9d7 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.04e-05 | 200 | 51 | 4 | 3dacd0afe69bc16bb33336ea9ea99a9cd47731d9 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.04e-05 | 200 | 51 | 4 | 3a164e3971bcd62b148b813171c103adb81f972e | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.04e-05 | 200 | 51 | 4 | f6cf98aad53aa8b3fa02cf874d6f7cd75530a213 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.04e-05 | 200 | 51 | 4 | ac8a5d71acd4d401995babd233f0d3738e8ad2a5 | |
| ToppCell | control-HLA-DR-_S100A+_Monocyte|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.04e-05 | 200 | 51 | 4 | 9e3e13a68bc1110fa000ec2d80f4c654ddbce17e | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.04e-05 | 200 | 51 | 4 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| ToppCell | 10x5'-Lung-Myeloid_Mac-Intestinal_macrophages|Lung / Manually curated celltypes from each tissue | 5.62e-04 | 141 | 51 | 3 | 7671d300b1722711fd2d8034b96a3aa7e3ccb560 | |
| ToppCell | 10x5'-bone_marrow-Hematopoietic_progenitors-Progenitor|bone_marrow / Manually curated celltypes from each tissue | 6.22e-04 | 146 | 51 | 3 | 035393166f3ad5ab95602a8ae11b7d0ee4b1d691 | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Monocytic-Cycling_mono|bone_marrow / Manually curated celltypes from each tissue | 6.47e-04 | 148 | 51 | 3 | de35eeefad0e27a0d127e2e4bedead2bddb75152 | |
| ToppCell | E18.5-samps-Mesenchymal-Pericyte-pericyte_B|E18.5-samps / Age Group, Lineage, Cell class and subclass | 6.86e-04 | 151 | 51 | 3 | 8ba15ab24fe2e71df0a2a7511ca451ad2376bd91 | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Thalamus / BrainAtlas - Mouse McCarroll V32 | 7.12e-04 | 153 | 51 | 3 | e9c6fb5c41adb6595c66c3a917fe455348279e54 | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Thalamus / BrainAtlas - Mouse McCarroll V32 | 7.12e-04 | 153 | 51 | 3 | b8b5ff7d2feea3e3a352fb5530e49f639fe1ff88 | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.12e-04 | 153 | 51 | 3 | 91e9d70a5d3f6fd68c284ed0cc113f03d7d1e10b | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.12e-04 | 153 | 51 | 3 | f17f62646633cf95c810dcd5328978058741b276 | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_TIP|Thalamus / BrainAtlas - Mouse McCarroll V32 | 7.12e-04 | 153 | 51 | 3 | 2513edfae62a44e51d3556675a096723194c966c | |
| ToppCell | 367C-Fibroblasts-Fibroblast-D-|367C / Donor, Lineage, Cell class and subclass (all cells) | 7.26e-04 | 154 | 51 | 3 | dd3d34f065820e706515a13619f19a5b12734c8e | |
| ToppCell | 367C-Fibroblasts-Fibroblast-D|367C / Donor, Lineage, Cell class and subclass (all cells) | 7.26e-04 | 154 | 51 | 3 | 4bfda1c41efbb86d829b3797d1168bf2587c3c97 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.40e-04 | 155 | 51 | 3 | 8fdda4e3657ac56188ae88ed3caf145f4d9d1567 | |
| ToppCell | severe_COVID-19-cDC|World / disease group, cell group and cell class (v2) | 7.54e-04 | 156 | 51 | 3 | 0a7e18ed8e13261c405eb6b9a183e99d8e1aac37 | |
| ToppCell | E12.5-Hematopoietic|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.68e-04 | 157 | 51 | 3 | 344351c7534440532c6cd4a95782ac90b10d45f3 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-F|368C / Donor, Lineage, Cell class and subclass (all cells) | 7.68e-04 | 157 | 51 | 3 | 74038192f016f95f80e0189035ee8ccc22ceb1b8 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-F-|368C / Donor, Lineage, Cell class and subclass (all cells) | 7.68e-04 | 157 | 51 | 3 | 982e6ea78c7dabdb7c07c4a5fb2425d5e45b5b94 | |
| ToppCell | COVID_non-vent-Myeloid-Monocytic-SC_&_Eosinophil|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 7.82e-04 | 158 | 51 | 3 | 0d4fe87fc7901dd5f9c004e91708a03cafdb4ad9 | |
| ToppCell | facs-Lung-EPCAM-3m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.82e-04 | 158 | 51 | 3 | b0508a600994090c6aafd8d779437190a33ad821 | |
| ToppCell | facs-Lung-EPCAM-3m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.82e-04 | 158 | 51 | 3 | a816cc095452308d06f87b77467e2a8c6361fd2a | |
| ToppCell | E18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.11e-04 | 160 | 51 | 3 | 4a0ae0a83a10dbfc13591f4d2228ba8bcd2c2275 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.11e-04 | 160 | 51 | 3 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | NS-critical-d_16-33-Myeloid-Mast_cell|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.11e-04 | 160 | 51 | 3 | c61869d9dbba250270e59366e15af204e5b4395d | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.11e-04 | 160 | 51 | 3 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-E|368C / Donor, Lineage, Cell class and subclass (all cells) | 8.41e-04 | 162 | 51 | 3 | e17632778a57c71d6005d3abca3a0443a92040e7 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-E-|368C / Donor, Lineage, Cell class and subclass (all cells) | 8.41e-04 | 162 | 51 | 3 | ac4a80fd72c9311ea2b3e574c6284bbce4f2756c | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Myeloid-neutrophil|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.56e-04 | 163 | 51 | 3 | abec4389cd88252449f110fe95416d67424b403a | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 8.56e-04 | 163 | 51 | 3 | 63b0badaee3b2d827b1f4524510e3384d8f8fcde | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-like|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.56e-04 | 163 | 51 | 3 | 360cd65decda24853124f33a174f5224d7f3ce23 | |
| Drug | rapamycin, Streptomyces hygroscepicus; Up 200; 0.1uM; MCF7; HT_HG-U133A | 4.92e-06 | 196 | 51 | 6 | 5975_UP | |
| Drug | Drofenine hydrochloride [548-66-3]; Down 200; 11.4uM; PC3; HT_HG-U133A | 5.52e-06 | 200 | 51 | 6 | 7129_DN | |
| Disease | connective tissue disease (implicated_via_orthology) | 4.30e-09 | 3 | 49 | 3 | DOID:65 (implicated_via_orthology) | |
| Disease | anemia (phenotype), response to ribavirin | 3.59e-07 | 9 | 49 | 3 | EFO_0004272, GO_1901559 | |
| Disease | scoliosis (is_implicated_in) | 1.62e-05 | 4 | 49 | 2 | DOID:0060249 (is_implicated_in) | |
| Disease | aortic aneurysm | 1.21e-04 | 10 | 49 | 2 | EFO_0001666 | |
| Disease | lung cancer (is_implicated_in) | 2.57e-04 | 74 | 49 | 3 | DOID:1324 (is_implicated_in) | |
| Disease | Gastro-enteropancreatic neuroendocrine tumor | 2.80e-04 | 15 | 49 | 2 | C2930967 | |
| Disease | multiple sclerosis | 4.35e-04 | 594 | 49 | 6 | MONDO_0005301 | |
| Disease | insulin sensitivity measurement, body mass index | 4.54e-04 | 19 | 49 | 2 | EFO_0004340, EFO_0004471 | |
| Disease | Lung Injury | 5.56e-04 | 21 | 49 | 2 | C0273115 | |
| Disease | Chronic Lung Injury | 5.56e-04 | 21 | 49 | 2 | C2350344 | |
| Disease | FEV/FEC ratio | 8.68e-04 | 1228 | 49 | 8 | EFO_0004713 | |
| Disease | colorectal cancer (is_implicated_in) | 1.08e-03 | 121 | 49 | 3 | DOID:9256 (is_implicated_in) | |
| Disease | spontaneous coronary artery dissection | 1.22e-03 | 31 | 49 | 2 | EFO_0010820 | |
| Disease | pack-years measurement, systolic blood pressure | 1.46e-03 | 34 | 49 | 2 | EFO_0006335, EFO_0006526 | |
| Disease | hepatocellular carcinoma (is_marker_for) | 1.57e-03 | 301 | 49 | 4 | DOID:684 (is_marker_for) | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 1.61e-03 | 139 | 49 | 3 | DOID:3908 (is_implicated_in) | |
| Disease | colon cancer (is_implicated_in) | 1.64e-03 | 36 | 49 | 2 | DOID:219 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ECMDGILDESLLETC | 4051 | Q9NR09 | |
| GGCEEEEDDHMEFCR | 406 | Q8TDI0 | |
| VCDEPRDREAVCAME | 791 | Q86TB3 | |
| RDREAVCAMECFEAG | 796 | Q86TB3 | |
| LIFSGMDLCDCLDED | 201 | Q8N8R7 | |
| LECRFFDCMGEEDLI | 146 | Q4KMX7 | |
| DMDGATLCNCALEEL | 96 | P78545 | |
| DRMGEEICACIRLKD | 546 | Q96CM8 | |
| PDMRTCVDVDECDLN | 1231 | Q75N90 | |
| EREDAILEEGMERFC | 101 | Q8IWE4 | |
| EADMELEFLETACAC | 786 | P98198 | |
| EDCALRMVDRLADGC | 201 | Q149M9 | |
| MDCEEDIDDCLANPC | 906 | Q04721 | |
| LECRFFDCMGEEDLI | 146 | P0CH98 | |
| CDREDDCGDQTDEMA | 946 | Q9NZR2 | |
| RCDADADCMDGSDEE | 3631 | Q07954 | |
| ALKDGECEDVDECAM | 756 | P98095 | |
| EDACDDIMLADDDCL | 51 | Q9NQP4 | |
| DFEAECCIVLDGMEL | 546 | Q92628 | |
| CDKFLDDDITDDIMC | 96 | P00709 | |
| DTDQEEEEACMARLC | 206 | Q6UWV2 | |
| CEMNGEECAEDLRML | 71 | Q13422 | |
| RDLCHMANGIEDCDD | 161 | Q9H160 | |
| VCCIDEFDKMAEADR | 441 | P33993 | |
| CLSDADCVAGELDML | 136 | Q9UBL9 | |
| SCDLEDDDLMLDVDL | 546 | Q9H7U1 | |
| MDDDDDSCLLDLIGD | 1 | Q6AI39 | |
| EVLADFMGRIDELCD | 181 | Q07973 | |
| DRRMCKDEDECEEGK | 2241 | P35555 | |
| EVVREICAEKGCEDM | 611 | A8TX70 | |
| EEEGDLCRICQMAAA | 546 | Q9H992 | |
| DVLMEALEALGCECR | 91 | A4GXA9 | |
| LDMEERNCTDIDECR | 1106 | P35556 | |
| DECAEGLHDCESRGM | 2296 | P35556 | |
| MDDEDGRCLLDVICD | 1 | Q9NZM4 | |
| DALNEIVRCICEMDE | 676 | A8MW92 | |
| MCRKVLCGDAGEDAE | 721 | O15397 | |
| CRPELEAETMELDEC | 191 | Q8N2Y8 | |
| DEKCTICLSMLEDGE | 291 | Q6ZSG1 | |
| LCTCIEMFDDNGELD | 16 | Q8IV61 | |
| CIGDAETDDEMCIAR | 71 | Q9UNA1 | |
| LCDDEQTLDCLETAM | 176 | Q96I34 | |
| LECDGAREREDTMEA | 1161 | Q9P2F8 | |
| DDMDIDCLTREELGD | 681 | Q12816 | |
| LQDEEDDSLCRICMD | 316 | Q969K3 | |
| DDSLCRICMDAVIDC | 321 | Q969K3 | |
| DEEECCICMDGRADL | 151 | Q8WVD5 | |
| DADNCEEVVRECAIM | 506 | Q86VQ3 | |
| EEELERLEEACDMAL | 181 | Q8WWY3 | |
| DECELDMRGGCHTDA | 906 | Q9NY15 | |
| EDDEMQLCVVCREAG | 111 | Q9UDY6 | |
| MERCTCDEAPDLENR | 146 | O14904 | |
| REQEVLDCDCDMASV | 261 | Q96BZ9 | |
| CECLFQAEDRDDMLA | 1016 | Q5T5U3 | |
| RDMDLLGCLEDIEEA | 426 | P19438 |